Free Trial
ASX:AVN

Aventus Group (AVN) Stock Price, News & Analysis

Aventus Group logo

About Aventus Group Stock (ASX:AVN)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1.17 million shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
5.50%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aventus Group and its competitors with MarketBeat's FREE daily newsletter.

AVN Stock News Headlines

Buffett’s $325 Billion Cash Problem — Solved by Gold?
A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most investors are still asleep… but not for long. Garrett Goggin’s latest research reveals how you can “front-run” the greatest investor alive by positioning in four small miners sitting on up to 100X potential upside. When this hits the news — it’ll be too late.
Aventus Law Group Offers New Hope for Taxpayers Facing IRS Disputes
Where I would invest my Fortescue dividends
See More Headlines

AVN Stock Analysis - Frequently Asked Questions

Aventus Group (ASX:AVN) announced its quarterly earnings data on Thursday, February, 14th. The company reported $0.09 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by $0.00.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aventus Group investors own include Milestone Pharmaceuticals (MIST), Ovintiv (OVV), SIG (SHI), Allena Pharmaceuticals (ALNA), Alpine Immune Sciences (ALPN), Affiliated Managers Group (AMG) and Aravive (ARAV).

Company Calendar

Last Earnings
2/14/2019
Today
7/12/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
REIT - Retail
Sub-Industry
N/A
Current Symbol
ASX:AVN
CIK
N/A
Fax
N/A
Employees
147,000
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
3.81
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
35.13
Current Ratio
0.38
Quick Ratio
0.33

Sales & Book Value

Annual Sales
A$182.80 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
104.71
Book Value
A$3.35 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
571,366,976
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (ASX:AVN) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners